Vetoquinol SA (0O1O.L)

EUR 76.5

(0.0%)

Total Assets Summary of Vetoquinol SA

Vetoquinol SA's latest annual total assets in 2023 was 692.23 Million EUR , up 6.2% from previous year.
Vetoquinol SA's latest quarterly total assets in 2024 Q2 was 706.41 Million EUR , down 0.0% from previous quarter.
Vetoquinol SA reported annual total assets of 651.84 Million EUR in 2022, up 4.37% from previous year.
Vetoquinol SA reported annual total assets of 624.56 Million EUR in 2021, down -3.33% from previous year.
Vetoquinol SA reported quarterly total assets of 692.23 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Vetoquinol SA reported quarterly total assets of 692.23 Million EUR for 2023 FY, up 6.2% from previous quarter.

Annual Total Assets Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Total Assets of Vetoquinol SA (2023 - 2005)

Year	Total Assets	Total Assets Growth
2023	692.23 Million EUR	6.2%
2022	651.84 Million EUR	4.37%
2021	624.56 Million EUR	-3.33%
2020	646.09 Million EUR	26.32%
2019	511.46 Million EUR	9.86%
2018	465.58 Million EUR	4.87%
2017	443.97 Million EUR	1.09%
2016	439.17 Million EUR	6.47%
2015	412.47 Million EUR	-1.64%
2014	419.36 Million EUR	19.19%
2013	351.83 Million EUR	-1.29%
2012	356.43 Million EUR	11.98%
2011	318.31 Million EUR	2.86%
2010	309.44 Million EUR	9.09%
2009	283.66 Million EUR	19.98%
2008	236.43 Million EUR	3.51%
2007	228.4 Million EUR	8.44%
2006	210.62 Million EUR	5.46%
2005	199.71 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	706.41 Million EUR	0.0%
2023 Q4	692.23 Million EUR	0.0%
2023 FY	692.23 Million EUR	6.2%
2023 Q2	649.13 Million EUR	0.0%
2022 Q4	651.84 Million EUR	0.0%
2022 Q2	625.31 Million EUR	0.0%
2022 FY	651.84 Million EUR	4.37%
2021 Q2	601.45 Million EUR	0.0%
2021 Q4	624.56 Million EUR	0.0%
2021 FY	624.56 Million EUR	-3.33%
2020 Q2	506.85 Million EUR	0.0%
2020 Q4	646.09 Million EUR	0.0%
2020 FY	646.09 Million EUR	26.32%
2019 FY	511.46 Million EUR	9.86%
2019 Q2	489.33 Million EUR	0.0%
2019 Q4	511.46 Million EUR	0.0%
2018 FY	465.58 Million EUR	4.87%
2018 Q4	465.58 Million EUR	0.0%
2018 Q2	441.54 Million EUR	0.0%
2017 FY	443.97 Million EUR	1.09%
2017 Q4	443.97 Million EUR	0.0%
2017 Q2	432.09 Million EUR	0.0%
2016 Q2	412.97 Million EUR	0.0%
2016 FY	439.17 Million EUR	6.47%
2016 Q4	439.17 Million EUR	0.0%
2015 FY	412.47 Million EUR	-1.64%
2015 Q2	424.05 Million EUR	0.0%
2015 Q4	412.47 Million EUR	0.0%
2014 Q2	388.22 Million EUR	0.0%
2014 FY	419.36 Million EUR	19.19%
2014 Q4	419.36 Million EUR	0.0%
2013 Q4	351.83 Million EUR	0.0%
2013 FY	351.83 Million EUR	-1.29%
2013 Q2	352.16 Million EUR	0.0%
2012 Q4	356.43 Million EUR	0.0%
2012 Q2	334.97 Million EUR	0.0%
2012 FY	356.43 Million EUR	11.98%
2011 Q4	318.31 Million EUR	0.0%
2011 FY	318.31 Million EUR	2.86%
2010 Q2	289.25 Million EUR	0.0%
2010 Q4	309.44 Million EUR	0.0%
2010 FY	309.44 Million EUR	9.09%
2009 Q4	283.66 Million EUR	0.0%
2009 FY	283.66 Million EUR	19.98%
2008 FY	236.43 Million EUR	3.51%
2007 FY	228.4 Million EUR	8.44%
2006 FY	210.62 Million EUR	5.46%
2005 FY	199.71 Million EUR	0.0%

Peer Total Assets Comparison of Vetoquinol SA

Name	Total Assets	Total Assets Difference
Boiron SA	590.2 Million EUR	-17.288%
Laboratorios Farmaceuticos Rovi, S.A.	799.88 Million EUR	13.458%
Valneva SE	469.39 Million EUR	-47.474%
AB Science S.A.	25.49 Million EUR	-2614.742%
Nanobiotix S.A.	93.89 Million EUR	-637.225%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	-1249.196%
Vivoryon Therapeutics N.V.	30.82 Million EUR	-2145.392%
BioSenic S.A.	9.55 Million EUR	-7141.678%
ABIVAX Société Anonyme	327.06 Million EUR	-111.652%
Formycon AG	890.36 Million EUR	22.253%